Market Closed - Börse Stuttgart 17:56:25 28/05/2024 BST | ||
405.3 EUR | -1.20% |
Current month | +9.45% | ||
1 month | +9.10% |
Comparison chart between the derivative product and it's underlying value
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
Date | Price | Change |
---|---|---|
28/05/24 | 405.3 | -1.20% |
27/05/24 | 410.2 | +0.22% |
24/05/24 | 409.4 | +0.10% |
23/05/24 | 409 | +0.47% |
22/05/24 | 407 | +0.74% |
Delayed Quote Börse Stuttgart
Last update May 28, 2024 at 05:56 pm
More quotesStatic data
Product type | Certificats Discount |
---|---|
Buy / Sell | CALL |
Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
Issuer | Morgan Stanley |
WKN | ME7WVA |
ISIN | DE000ME7WVA4 |
Date issued | 30/01/2024 |
Cap | 450 $ |
Last trading day | 21/06/2024 |
Maturity | 21/06/2024 (24 Days) |
Parity | 1 : 1 |
Emission price | 383.2 € |
Emission volume | N/A |
Payment day | 28/06/2024 |
Bonus | - € |
Settlement | règlement en espèces |
Currency | EUR |
Technical Indicators
Discount (ask) | 0.000000 % |
---|---|
Sideways yield | 0.000000 % |
Sideways yield pa | 0.000000 % |
Outperformance point | - $ |
Break even | 0.000000 € |
Highest since issue | 410.2 € |
Lowest since issue | 363.9 € |
Distance Cap | -3.12 $ |
Distance Cap % | -0.70% |
Max. earning | - |
Max. earning % | 0.000000 % |
Company Profile
Ratings for Vertex Pharmaceuticals Incorporated
Consensus: Vertex Pharmaceuticals Incorporated
- Stock Market
- Certificates
- Certificat